Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
Third Quarter 2022: Increase in Reservations and Multiple International Partnerships Signed
-
Third Quarter 2022: Increase in Reservations and Multiple International Partnerships Signed
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Generac, and Veru and Encourages Investors to Contact the Firm
-
ADMA Biologics (ADMA) Prices Public Offering for $60 Million of Common Stock
-
ADMA Biologics Announces Pricing of Public Offering for $60 Million of Common Stock
-
ADMA Biologics Announces Pricing of Public Offering for $60 Million of Common Stock
-
X4 Pharmaceuticals (XFOR) Prices $65.0 Million Public Offering of Common Stock, Warrants
-
X4 Pharmaceuticals Prices $65.0 Million Public Offering
-
Cantor Fitzgerald Calls Udemy Inc (UDMY) New Top Pick
-
X4 Pharmaceuticals (XFOR) to Offer Common Stock
-
X4 Pharmaceuticals Announces Proposed Public Offering
-
ADMA Biologics Announces Proposed Public Offering of Common Stock
-
ADMA Biologics Announces Proposed Public Offering of Common Stock
-
Form SC 13G Jaguar Global Growth Filed by: CANTOR FITZGERALD SECURITIES
-
Form SC 13G Cartica Acquisition Corp Filed by: CANTOR FITZGERALD SECURITIES
-
Form SC 13G Infinite Acquisition Filed by: CANTOR FITZGERALD SECURITIES
-
Form SC 13G Target Global Acquisitio Filed by: CANTOR FITZGERALD SECURITIES
-
Cantor Fitzgerald remains bullish after touring Lucid's (LCID) Arizona facility
-
Veru, Inc. (VERU) PT Lowered to $22 at Cantor Fitzgerald
-
Organogenesis Holdings Inc. to Participate in the Cantor Fitzgerald Medical and Aesthetic Dermatology, Ophthalmology and Medtech Conference
-
Jeune Aesthetics to Participate in the Cantor Fitzgerald Medical and Aesthetic Dermatology, Ophthalmology and Medtech/Diagnostic Conference
-
Form 8-K Cantor Fitzgerald Income For: Nov 30
-
VYNE Therapeutics to Participate in Cantor Fitzgerald’s Medical & Aesthetic Dermatology, Ophthalmology & MedTech Conference
-
Edesa Biotech to Participate in the 2022 Cantor Fitzgerald Dermatology Conference
-
NeuroSense Announces Third Quarter 2022 Financial Results and Provides Business Update
-
Aziyo Biologics (AZYO) Announces Pricing of $11.2 Million Public Offering of Common Stock
-
Aziyo Biologics, Inc. Announces Pricing of $11.2 Million Public Offering of Common Stock
-
Novan to Participate in the Cantor Fitzgerald Medical & Aesthetic Dermatology, Ophthalmology & Medtech Conference
-
Novan to Participate in the Cantor Fitzgerald Medical & Aesthetic Dermatology, Ophthalmology & Medtech Conference
-
Outlook Therapeutics® to Participate in the Cantor Fitzgerald Medical & Aesthetic Dermatology, Ophthalmology & Medtech Conference
-
Akari Therapeutics to Participate in the Cantor Fitzgerald Medical and Aesthetic Dermatology, Ophthalmology and Medtech/Diagnostic Conference
-
Akari Therapeutics to Participate in the Cantor Fitzgerald Medical and Aesthetic Dermatology, Ophthalmology and Medtech/Diagnostic Conference
-
Aziyo Biologics (AZYO) Announces Proposed Public Offering of Common Stock
-
Aziyo Biologics, Inc. Announces Proposed Public Offering of Common Stock
-
Cantor Fitzgerald Upgrades SoundHound AI Inc. (SOUN) to Overweight
-
EF Hutton Expands Healthcare Franchise with Appointments of Veteran Equity Research Analysts
-
EF Hutton Expands Healthcare Franchise with Appointments of Veteran Equity Research Analysts
-
EF Hutton Expands Healthcare Franchise with Appointments of Veteran Equity Research Analysts
-
Alaunos Therapeutics (TCRT) Prices Public Offering of Common Stock for Gross Proceeds of Approximately $15.7 Million
-
Alaunos Therapeutics Announces Pricing of Public Offering of Common Stock
-
Lineage to Present at BTIG Ophthalmology Day and the Cantor Fitzgerald Medical & Aesthetic Dermatology, Ophthalmology & MedTech Conference
-
Alaunos Therapeutics (TCRT) Announces Proposed Public Offering of Common Stock
-
Alaunos Therapeutics Announces Proposed Public Offering of Common Stock
-
Form NPORT-P CANTOR FITZGERALD SUSTAI For: Sep 30
-
Form APP NTC CANTOR FITZGERALD SUSTAI
-
Cantor Fitzgerald Downgrades Opiant Pharma (OPNT) to Neutral on Acqusition
-
Redhill Biopharma (RDHL) PT Lowered to $1 at Cantor Fitzgerald
-
Mainz Biomed to Participate in Deutsche Eigenkapitalforum and Cantor Fitzgerald’s Medical & Aesthetic Dermatology, Ophthalmology & MedTech Conference
-
OcuTerra to Participate in Upcoming Investor Conferences
-
Mainz Biomed to Participate in Deutsche Eigenkapitalforum and Cantor Fitzgerald’s Medical & Aesthetic Dermatology, Ophthalmology & MedTech Conference


